Defense Advanced Research Projects Agency - DARPA

Defense Advanced Research Projects Agency - DARPA Official page of the U.S. Defense Advanced Research Projects Agency (DARPA) www.darpa.mil DARPA's mission is to prevent and create strategic technological surprise by maintaining the technological superiority of the U.S.
(146)

military. The Agency sponsors revolutionary, high-payoff research bridging the gap between fundamental discoveries and their military use.

Operating as usual

AI’s first wave: expert systems; chess, and taxes. AI’s second wave: statistical learning; image recognition and autonom...
11/18/2020

AI’s first wave: expert systems; chess, and taxes. AI’s second wave: statistical learning; image recognition and autonomous driving. AI’s third wave: contextual reasoning; computers with common sense. Learn how DARPA has been advancing AI for 50+ years. https://go.usa.gov/x7kqy

Here are the teams whose robots came out on top in the virtual underground! DARPA #SubTChallenge announces Cave Circuit ...
11/17/2020

Here are the teams whose robots came out on top in the virtual underground! DARPA #SubTChallenge announces Cave Circuit Virtual Competition winners and $500,000 in prizes. https://www.darpa.mil/news-events/2020-11-17

11/17/2020

In just one hour, watch teams compete in the #SubTChallenge Cave Circuit Virtual Competition (2:00PM ET) at www.subtchallenge.com and get inspired to create your own solutions using open source tools such as Robot Operating Systems (ROS) via www.subtchallenge.world

11/17/2020

Check out final preparations for broadcast of the #SubTChallenge Virtual Cave Competition that's happening TODAY! Tune in at www.subtchallenge.com this afternoon (2PM EST) for all the action and find out who wins the $500K worth of prizes during the awards ceremony!

In 2013, DARPA chose to support Moderna’s mRNA therapeutics and vaccine development through our ADEPT (Autonomous Diagno...
11/16/2020
Moderna Announces Positive Phase 1 Results for the First Systemic Messenger RNA Therapeutic Encoding a Secreted Protein (mRNA-1944)

In 2013, DARPA chose to support Moderna’s mRNA therapeutics and vaccine development through our ADEPT (Autonomous Diagnostics to Enable Prevention and Therapeutics) program. In September 2019, in accordance with program goals, the company announced positive Phase 1 safety and efficacy data for mRNA-1944, which encodes for an antibody against chikungunya virus.

The company announced today that their experimental coronavirus vaccine, built in part on this groundbreaking work, is nearly 95 percent effective at preventing COVID infection: https://www.businesswire.com/news/home/20190912005422/en/Moderna-Announces-Positive-Phase-1-Results-for-the-First-Systemic-Messenger-RNA-Therapeutic-Encoding-a-Secreted-Protein-mRNA-1944

Moderna, Inc. announces positive Phase 1 results for the first systemic messenger RNA therapeutic encoding a secreted protein (mRNA-1944).

We've selected teams to advance dogfighting algorithms for our ACE program. Five companies will develop AI to handle dog...
11/12/2020

We've selected teams to advance dogfighting algorithms for our ACE program. Five companies will develop AI to handle dogfights involving multiple aircraft. AI will be tested in modeling & sim, sub-scale unmanned aircraft, and full-scale aircraft in 2023: https://www.darpa.mil/news-events/2020-11-11

Implementing best practice public health measures on their own among young adults may not be enough to prevent SARS-CoV-...
11/12/2020

Implementing best practice public health measures on their own among young adults may not be enough to prevent SARS-CoV-2 transmission and additional actions, such as widespread and repeated testing is recommended to reduce risk of viral spread, according to research published today in the New England Journal of Medicine.

Researchers from @NavalMedicalRC in collaboration with scientists from the @IcahnMountSinai, conducted a study to understand the dynamics of viral transmission and host response to COVID-19 in young adults in order to inform public health measures in response to COVID-19 in a group setting.

The study, COVID-19 Health Action Response for Marines (CHARM), took place at Marine Corps Recruit Depot Parris Island and included nearly 2,000 participants comprised mostly of 18-20 year-old healthy Marine recruits predominantly from the Eastern U.S. Upon arrival for recruit training, they spent two weeks in a strict, supervised group quarantine that required wearing masks and emphasized hand washing and social distancing as they began their initial military instruction, primarily outdoors: https://www.nejm.org/doi/full/10.1056/NEJMoa2029717?query=TOC

DARPA is broadening its commitment to young scientists, engineers, and mathematicians through a new fellowship program f...
11/11/2020

DARPA is broadening its commitment to young scientists, engineers, and mathematicians through a new fellowship program focused on postdoctoral researchers in the field of computer science with grants sized to support each fellow for up to two years: https://www.darpa.mil/news-events/2020-11-11a

DARPA is broadening its commitment to young scientists, engineers, and mathematicians through a new fellowship program f...
11/11/2020

DARPA is broadening its commitment to young scientists, engineers, and mathematicians through a new fellowship program focused on postdoctoral researchers in the field of computer science with grants sized to support each fellow for up to two years: https://www.darpa.mil/news-events/2020-11-11a

Just two years into a four-year program, P3 has performers at AbCellera Biologics, AstraZeneca, Duke University, and Van...
11/10/2020

Just two years into a four-year program, P3 has performers at AbCellera Biologics, AstraZeneca, Duke University, and Vanderbilt University, all of whom have been able to quickly pivot to rapidly identify antibodies for COVID-19 in less than 90-days. This process traditionally takes several years to complete.

Yesterday, AbCellera announced that a human antibody identified as part of the P3 program and in conjunction with the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Center (VRC), bamlanivimab (LY-CoV555), had been granted emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the treatment of patients 12 years of age and older with mild to moderate COVID-19. AbCellera was able to obtain a sample of blood at the end of February via an intergovernmental panel, and identified over 1,000 potential antibody candidates. They then began testing how well these antibodies bind to and neutralize the virus to prevent them from entering human cells (photo courtesy of Vanderbilt): https://www.darpa.mil/news-events/2020-11-10

Spinal cord injury (SCI) is of significant concern to the Department of Defense. Of the 337,000 Americans with serious S...
11/10/2020

Spinal cord injury (SCI) is of significant concern to the Department of Defense. Of the 337,000 Americans with serious SCIs, approximately 44,000 are veterans, with 11,000 new injuries occurring each year. SCI is a complex condition – the injured often face lifelong paralysis and increased long-term morbidity due to factors such as sepsis and autonomic nervous system dysfunction. While considerable research efforts have been devoted toward restorative and therapeutic technologies to SCIs, significant challenges remain.

DARPA’s Bridging the Gap Plus (BG+) program aims to develop new approaches to treating SCI by integrating injury stabilization, regenerative therapy, and functional restoration. Today, DARPA announced the award of contracts to the University of California-Davis, Johns Hopkins University, and the University of Pittsburgh to advance this crucial work. Multidisciplinary teams at each of these universities are tasked with developing systems of implantable, adaptive devices that aim to reduce injury effects during early phases of SCI, and potentially restore function during the later chronic phase.

Learn more about DARPA’s BG+ program at: https://www.darpa.mil/news-events/2020-11-09

In this episode of the Voices from DARPA podcast, Tom Rondeau, a program manager since 2016, takes listeners on a tour o...
11/05/2020

In this episode of the Voices from DARPA podcast, Tom Rondeau, a program manager since 2016, takes listeners on a tour of his efforts to usher wireless technology into a new era. Anchored in an emerging technology arena known as software-defined radio (SDR), his programs dive deeply into the pathbreaking hardware, software, computational techniques, power efficiencies, and innovation communities that it will take to do more with the electromagnetic spectrum than ever before. Think of every cellphone call ever made, of satellite communication, and now of billions of devices communicating wirelessly via apps and the internet. And now think beyond all of that. The tattoos of Maxwell’s Equations — which famously capture the behavior of electromagnetic waves as discerned by the 19th century physicist James Clerk Maxwell — on Tom’s forearms reveal just how devoted he is to his technology-development mission. “I look down at those every day and have a moment of awe about what we have been able to do,” he tells listeners. And then he has another moment of awe as he imagines how much more he might be able to pull off as a DARPA program manager. https://www.darpa.mil/about-us/podcast

ICYMI: Read about DARPA's Make-It performers @CroninLab, @SRI_Intl who are speeding up the discovery and production of m...
11/03/2020
Scientists make digital breakthrough in chemistry that could revolutionize the drug industry

ICYMI: Read about DARPA's Make-It performers @CroninLab, @SRI_Intl who are speeding up the discovery and production of molecules by digitizing chemical synthesis with advanced automated synthesis platforms: https://www.cnbc.com/2020/10/24/how-a-digital-breakthrough-could-revolutionize-drug-industry.html

At the Cronin Lab at the University of Glasgow chemists developed a robotic chemist called a "chemputer" that turns words into molecules.

10/29/2020
DARPA Subterranean Challenge Virtual Competition

Teams that qualified for the #SubTChallenge Cave Circuit Virtual Competition recently submitted their algorithms for autonomously navigating and searching underground cave environments. Tune in on Nov 17 at 2pm EST to watch them perform and see who wins: https://www.youtube.com/watch?v=gSMiLLx8Y0Y&feature=youtu.be

The DARPA Subterranean (SubT) Challenge aims to develop innovative technologies that would augment operations underground. The SubT Challenge explores new ap...

DARPA’s SIGMA+ program recently conducted a deployment of advanced chemical and biological sensing systems in the Indian...
10/21/2020

DARPA’s SIGMA+ program recently conducted a deployment of advanced chemical and biological sensing systems in the Indianapolis area, collecting more than 250 hours of atmospheric data, which will help train algorithms to more accurately detect threats: https://www.darpa.mil/news-events/2020-10-21

One of the core processes of development biology involves establishing positions of various cells within a tissue, calle...
10/19/2020

One of the core processes of development biology involves establishing positions of various cells within a tissue, called morphogenesis. DARPA BETR performers at @UCSF recently demonstrated in @ScienceMagazine that synthetic green fluorescent protein (GFP) signals can be substituted for a natural morphogen to organize patterning.

The BETR program aims to provide medical interventions with the necessary sophistication to more quickly restore complex human tissues after injury. The effort notably focuses on injuries relevant to the warfighter such as blast and burn damage to bone, skin, and nerves. If the program succeeds, warfighters could return to duty sooner and more fully healed: https://science.sciencemag.org/content/370/6514/327

In the latest Voices from DARPA episode, meet program manager Stacie Williams and learn how her childhood love for the l...
10/19/2020

In the latest Voices from DARPA episode, meet program manager Stacie Williams and learn how her childhood love for the light fantastique of fireflies expresses itself at DARPA in R&D programs that could transform telescope technology: https://www.darpa.mil/about-us/podcast

DARPA program manager Stacie Williams is shepherding R&D that could lead to do a major shrink job on complex, expensive ...
10/16/2020

DARPA program manager Stacie Williams is shepherding R&D that could lead to do a major shrink job on complex, expensive and massive orbiting telescopes. Listen to what she is up to in the latest Voices from DARPA podcast episode: https://youtu.be/RYlPFCFfhTA

DARPA has awarded seven contracts for work on the NOMARS program, which seeks to maximize seaframe performance when huma...
10/13/2020

DARPA has awarded seven contracts for work on the NOMARS program, which seeks to maximize seaframe performance when human constraints are removed and achieve vessel maintenance and logistics functionality for long endurance operations: https://www.darpa.mil/news-events/2020-10-13

DARPA was honored to host this week Congressman @MacThornberry, Ranking Member on the House Armed Services Cmte. Thornbe...
10/08/2020

DARPA was honored to host this week Congressman @MacThornberry, Ranking Member on the House Armed Services Cmte. Thornberry, seen here with DARPA director Dr. Victoria Coleman, met with researchers to discuss COVID-19 response efforts and microelectronics, among other topics.

10/07/2020

DARPA would like to congratulate Safe Genes PI Jennifer Doudna & her team for being awarded the 2020 #NobelPrize in Chemistry! Their pioneering work on #CRISPR is contributing to novel cancer therapies, and holds promise for curing inherited diseases: https://www.nobelprize.org/prizes/chemistry/2020/summary/

DARPA's 2021 Young Faculty Award (YFA) research announcement is now available. Learn more about the YFA program, eligibi...
10/07/2020

DARPA's 2021 Young Faculty Award (YFA) research announcement is now available. Learn more about the YFA program, eligibility, and the topic areas where DARPA is soliciting innovative research proposals: https://go.usa.gov/xGMax

Are you a novel hard-tech scientist and entrepreneur in need of lab space and top-notch mentors? Applications for the @a...
10/01/2020
Apply — Activate

Are you a novel hard-tech scientist and entrepreneur in need of lab space and top-notch mentors? Applications for the @activatefellows program are now open! @DARPA is a proud partner for discovery of next generation #microsystems and #microelectronics. Tune in 10/6 to learn more.
https://www.activate.org/apply

Already think you’ll be applying? Pre-apply now if you want to join specialized workshops on how to prepare for the application process, get introductions to fellows, and insights on how to connect with potential technical collaborators.

DARPA's FETT Bug Bounty is in its final week, but there is still time to participate before the Oct. 6 close. To date, m...
09/30/2020

DARPA's FETT Bug Bounty is in its final week, but there is still time to participate before the Oct. 6 close. To date, more than 500 hackers have spent in excess of 10k hours searching for exploits. Learn more at: https://fett.darpa.mil/

09/30/2020
Covid on chips

Missed our August update on the DARPA-funded team at Cambridge University developing electronic biosensors to detect coronavirus with high sensitivity? Their research was just highlighted on BBC [Link: https://www.youtube.com/watch?v=__jQtojk4kk

Amazing work to find new drugs to fight Covid...by using microchips. Featuring Dr Anna-Maria Pappa, Research Fellow, University of Cambridge Walther Traberg-...

Congratulations to the 17 Virtual Competition teams that qualified for the #SubTChallenge Cave Circuit! Save the date to...
09/28/2020

Congratulations to the 17 Virtual Competition teams that qualified for the #SubTChallenge Cave Circuit! Save the date to see teams' robots conquer diverse cave worlds on 17 NOV on the Showcase & Awards Ceremony stream: http://www.darpa.mil/news-events/2020-09-28a

Address

675 N Randolph St
Arlington, VA
22203-2114

General information

We are happy to facilitate discussions about DARPA's work within the online community and ask that all participants adhere to our comment policy when choosing to engage with this page. DARPA reserves the right to review, edit, move or delete any material submitted as a comment or placed on this profile, without notice. Comments will be reviewed and inappropriate comments may be deleted at DARPA's sole discretion. We hope to receive submissions from everyone, but we ask that all participants agree to the following Terms of Participation: • Please post only comments or questions about or related to DARPA and its research. • Refrain from posting comments that contain threats, obscenity, material that would violate the law if published here, abusive, defamatory or sexually explicit material. • Submissions containing the following will be deleted: o Contains obscene or threatening language or discrimination (hate speech). o Promotes services or products (not including non-commercial links that are relevant to the topic) including spam. o Includes any personal or sensitive information (e.g., phone numbers, email or postal addresses) o Includes information that might violate military operational security (OPSEC).

Alerts

Be the first to know and let us send you an email when Defense Advanced Research Projects Agency - DARPA posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Videos